Women's Questions About Perinatal Cannabis Use and Health Care Providers' Responses.

Kelly C Young-Wolff¹, Kathleen Gali², Varada Sarovar¹, Geoffrey W Rutledge³, Judith J Prochaska²

¹Division of Research, Kaiser Permanente Northern California, Oakland, California.

²Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California.

³HealthTap, Mountain View, California.

PubMed PMC DOI PDF

Abstract

Background: Cannabis use is common among individuals of reproductive age. We examined publicly posted questions about perinatal cannabis use and licensed United States health care provider responses. Materials and Methods: Data were medical questions on perinatal cannabis use posted online from March 2011 to January 2017 on an anonymous digital health platform. Posters were able to "thank" health…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Mentioned Companies

HealthTap
affiliation

NIH Funding

Grant #10146321
Identifying Risk Factors for Prenatal Substance and Polysubstance Use
KAISER FOUNDATION RESEARCH INSTITUTE
$181,592 (FY2021)

Other Funding

NIDA NIH HHS(K01 DA043604)
United States
NHLBI NIH HHS(T32 HL007034)
United States

MeSH Terms

Adult0Attitude of Health Personnel0Breast Feeding0Cannabis0Female0Health Personnel0Humans0Marijuana Abuse0Obstetrics0Physician-Patient Relations0Pregnancy0Pregnancy Complications0Prenatal Care0Surveys and Questionnaires0United States0

Keywords

breast feedingmarijuanapostpartumpregnancyprenatalprovider

Article Info

PMID: 32011205
PMCID: PMC7371546
DOI: 10.1089/jwh.2019.8112

How to Cite

Young-Wolff KC et al. Women's Questions About Perinatal Cannabis Use and Health Care Providers' Responses. J Womens Health (Larchmt)2020;29(7):919-926. doi:10.1089/jwh.2019.8112

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.